JENNIFER MONTGOMERY: Open Payments
NPI 1568658698 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 17 payments from 8 companies in 2025. Trend: 2023 $191 · 2024 $333 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Janssen Pharmaceuticals, Inc | 3 | $96 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Hologic Sales and Service, LLC | 1 | $28 |
| Novo Nordisk Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: AIRSUPRA, SPRAVATO, SHINGRIX, APTIMA, Ozempic, MOUNJARO, ZORYVE, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
